Table 4.
Peak CK‐MB and NT pro‐BNP predicting 90‐day mortality in UMCG STEMI registry
| Factor | Hazard Ratio | P | Confidence Interval |
|---|---|---|---|
| Peak CK‐MB ≥210 and <380 U/L | 3.39 | 0.001 | 1.69‐6.80 |
| Peak CK‐MB >380 U/L | 7.47 | <0.001 | 4.05‐13.78 |
| Age per year | 1.04 | <0.001 | 1.02‐1.06 |
| Female | 0.64 | 0.16 | 0.34‐1.19 |
| Previous CAD 1 | 2.38 | 0.003 | 1.34‐4.21 |
| Diabetes | 1.10 | 0.768 | 0.59‐2.05 |
Abbreviations: CK‐MB, creatine kinase‐MB; CAD, coronary artery disease; NT pro‐BNP, N‐terminal pro‐brain natriuretic peptide; STEMI, ST‐segment elevation myocardial infarction; UMCG, University Medical Centre Groningen.
1
Previous CAD included history of PCI, coronary artery bypass surgery, and/or myocardial infarction.